Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the worldnews domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/u382397270/domains/mozocare.com/public_html/oncopod/wp-includes/functions.php on line 6114
ALIQOPA™ (Copanlisib) – Oncopod- Chemotherapy Drugs Information, Acronyms, Side effects
Oncopod
Contact Us
Oncopod
Menu

ALIQOPA™
(AL-ih-KO-pah)
Copanlisib

Chemotherapy 

Have a Question ?

ALIQOPA™
(AL-ih-KO-pah)
Copanlisib

Chemotherapy

Have a Question ?

What is ALIQOPA?

ALIQOPA is a prescription medicine used to treat adults with follicular lymphoma (FL) when the disease has come back after treatment with at least two prior medicines.

What is the most important information I should know about ALIQOPA?

ALIQOPA can cause serious side effects. These serious side effects include:

  • Infections. ALIQOPA can cause serious infections that may lead to death. The most common serious infection was pneumonia. Tell your healthcare provider right away if you have a fever or any signs of an infection during treatment with ALIQOPA.
  • High blood sugar (hyperglycemia). High blood sugar is common following ALIQOPA infusion and can sometimes be serious. Tell your healthcare provider if you develop any symptoms of hyperglycemia during treatment with ALIQOPA. Symptoms of hyperglycemia may include: being very hungry, headache, being very thirsty, frequent urination
  • High blood pressure (hypertension). High blood pressure is common following ALIQOPA infusion and can sometimes be serious.
  • Lung or breathing problems. Your healthcare provider may do tests to check your lungs if you have breathing problems during treatment with ALIQOPA. Tell your healthcare provider right away if you develop new or worsening cough, shortness of breath, or difficulty breathing.
  • Low white blood cell count (neutropenia). Neutropenia is common with ALIQOPA treatment and can sometimes be serious. Your healthcare provider will check your blood counts regularly during treatment with ALIQOPA. Tell your healthcare provider right away if you have a fever or any signs of infection during treatment with ALIQOPA.
  • Severe skin reactions. Skin peeling, rash, and itching are common with ALIQOPA and can sometimes be serious. Tell your healthcare provider if you develop skin peeling, itching, or rash during treatment with ALIQOPA. Your healthcare provider may withhold treatment, decrease your dose, or permanently stop treatment if you develop severe skin reactions during treatment with ALIQOPA.
  • The most common side effects of ALIQOPA include:
  • low white blood cell count (leukopenia)
  • decreased strength and tiredness
  • lower respiratory tract infection
  • nausea
  • diarrhea
  • low platelets in your blood (thrombocytopenia)

These are not all of the possible side effects of ALIQOPA. Call your doctor for medical advice about side effects.

How will I receive ALIQOPA?

  • ALIQOPA will be given to you by a healthcare provider as an intravenous (IV) injection into your vein over 1 hour.
  • You will receive your ALIQOPA treatment 1 time every week for 3 weeks and then stop for 1 week. This is 1 cycle of treatment. ALIQOPA is usually given on Day 1, Day 8, and Day 15 of a 28-day treatment cycle.
  • Your healthcare provider will decide how many treatment cycles you need.
  • Your healthcare provider may withhold treatment, decrease your dose, temporarily stop, or permanently stop treatment with ALIQOPA if you have certain side effects.

Insert text here

 

Nucleic Acid Diagnostic kit

Important Safety Information

  • Avoid taking St. John’s Wort during treatment with ALIQOPA.
  • Avoid drinking grapefruit juice during treatment with ALIQOPA.

Ask your healthcare provider if you do not know.

What should I tell my healthcare provider before taking ALIQOPA?

Before receiving ALIQOPA, tell your healthcare provider about all of your medical conditions, including if you:

  • have an infection
  • have lung or breathing problems
  • have high blood pressure (hypertension)
  • have diabetes or high blood sugar (hyperglycemia)
  • are pregnant or plan to become pregnant. ALIQOPA can harm your unborn baby.
  • Your healthcare provider will perform a pregnancy test before starting treatment with ALIQOPA.
  • Females who are able to become pregnant should use effective birth control (contraception) during treatment with ALIQOPA and for at least 1 month after the last dose of ALIQOPA. Talk to your healthcare provider about birth control methods that may be right for you. Tell your healthcare provider right away if you become pregnant or think you are pregnant during treatment with ALIQOPA.
  • Males with female partners who are able to become pregnant should use effective birth control (contraception) during treatment with ALIQOPA and for at least 1 month after the last dose of ALIQOPA.
  • are breastfeeding or plan to breastfeed. It is not known if ALIQOPA passes into your breast milk. Do not breastfeed during treatment with ALIQOPA and for at least 1 month after the last dose of ALIQOPA. Talk to your healthcare provider about the best way to feed your child during treatment with ALIQOPA.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Certain other medicines may affect how ALIQOPA works.

Available 24/7
Experiencing
symotoms that
concern you
Chat Online Now

It is not known if ALIQOPA is safe and effective in children

General information about ALIQOPA

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. You can ask your healthcare provider or pharmacist for information about ALIQOPA that is written for health professionals.

What are the ingredients in ALIQOPA?

Active ingredient: Copanlisib 

Other ingredient:  Citric acid anhydrous, mannitol, sodium hydroxide

Have questions about chemotherapy?

Contact for Second Opinion or Free Counselling

+91-882-688-3200
Available 24/7
Experiencing
symotoms that
concern you
Chat Online Now
Have questions
about cancer?
Just ask Alexa. Find voice-activated answers to 800+ questions on 40+ cancer types.
Learn How
trust.jpg

4.4/5 Trustpilot

search.png

4.4/5 . Google

About Mozocare

Mozocare is a medical access platform for hospitals and clinics to assist patients access best medical care at affordable prices. Mozocare Insights provides Health News, Latest treatment innovation, Hospital ranking , Healthcare Industry Information and Knowledge sharing .

Write For Us

Reach Us

Follow Us

Find a Hospital

Organ Transplant

Cancer Treatment

Specialised Surgery

Disclaimer: Content provided on mozocare is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this Website.

© 2024 Mozocare. All Rights Reserved. DMCA.com Protection Status